{"doi":"10.1360/zc2002-32-5-463","title":"从噬菌体展示的构象限制性随机肽库中筛选有 trkB 结合活性的小肽","abstract":null,"journal":"Science in China Series C-Life Sciences (in Chinese)","year":2002,"id":620423,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":0.0,"corpus_rank":10385,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":true,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"从噬菌体展示的构象限制性随机肽库中筛选有 trkB 结合活性的小肽","abstract":"脑源性神经营养因子(brain-derived neurotrophic factor, BDNF)能够促进多种神经元的存活和分化, 在神经退行性疾病的治疗中具有广阔的应用前景, 但由于其分子量大而无法穿过血脑屏障, 限制了其临床应用. 以表达于NIH 3T3细胞上的BDNF受体trkB为靶分子, 从噬菌体展示的随机肽库中筛选与trkB有亲和力的小肽, 采用不表达trkB 的NIH 3T3细胞预吸附和最后一轮筛选以1 <I>μ</I>g/mL的BDNF竞争性洗脱策略, 使能与trkB天然构象结合、又能有效拮抗BDNF与trkB结合的特异性噬菌体得到了有效富集, 获得了5种trkB结合小肽, 它们有核心序列CRA/TXφXXφXXC(X代表随机残基, φ为T, L或I). 对展示有5种外源小肽的噬菌体进行了初步生物活性测定, 未发现有BDNF样活性, 反而能剂量依赖性地拮抗BDNF的生物功能. 依据其中一个克隆序列(C1)合成的肽也证实有拮抗BDNF的作用, 表明获得的5种小肽可能为trkB受体拮抗剂. 这些trkB拮抗性小肽在治疗神经母细胞瘤和慢性痛以及神经生物学研究中具有应用前景, 同时也为构建二级噬菌体展示肽库、继续筛选BDNF模拟小肽奠定了基础.","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19910364","pmcid":null,"openalex_id":"https://openalex.org/W3143819467","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.4207686,"influential_citations":0,"citation_trend":[],"oa_status":"bronze","license":null,"oa_locations":[{"url":"https://www.sciengine.com/doi/pdf/d0e8394eda5740619b5c1aa8ede42ff2","host_type":"journal"},{"url":"https://www.sciengine.com/doi/pdf/d0e8394eda5740619b5c1aa8ede42ff2","host_type":"publisher"},{"url":"https://doi.org/10.1360/zc2002-32-5-463","host_type":"journal"}],"fields_of_study":["Cancer Research and Treatments","Pancreatic function and diabetes","Nerve injury and regeneration"],"mesh_terms":[],"keywords":["Tropomyosin receptor kinase B","Brain-derived neurotrophic factor","Neurotrophic factors","Neurotrophin","Neuroscience","Internal medicine","Medicine","Psychology","Receptor"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-03T11:01:34.402917Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}